News for CytoDyn Inc. Stock (CYDY)

CYDY ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 17, 2021 in the Class Action Filed on Behalf of CytoDyn Inc. Limited Shareholders

Newsfile Corp • 05/14/21

CYDY FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages CytoDyn Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - CYDY

Newsfile Corp • 05/14/21

CYDY LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving CytoDyn Inc.

Newsfile Corp • 05/14/21

DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Newsfile Corp • 05/14/21

Last Day For Shareholders With Losses Exceeding $400K to Actively Participate in CytoDyn, Inc. (CYDY) Class Action and Lead Plaintiff Deadline: May 17, 2021 - Bronstein, Gewirtz & Grossman, LLC

Business Wire • 05/14/21

CYTODYN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CytoDyn, Inc. - CYDY

Newsfile Corp • 05/14/21

Final Deadline Approaching on May 17, 2021: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Investors of Class Action Lawsuit Deadline

PRNewsWire • 05/13/21

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY)

Business Wire • 05/13/21

MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Newsfile Corp • 05/13/21

CytoDyn strikes supply and distribution deal with Indian firm for leronlimb as coronavirus treatment

Proactive Investors • 05/13/21

CytoDyn Signs Distribution Agreement with Macleods Pharmaceuticals Ltd. to Pursue EUA and Compassionate Use Access to Leronlimab in India

GlobeNewsWire • 05/13/21

Rosen, A Top Ranked Law Firm, Encourages CytoDyn Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CYDY

Newsfile Corp • 05/12/21

Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against CytoDyn Inc. (CYDY)

Business Wire • 05/12/21

MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Newsfile Corp • 05/12/21

CYDY ALERT: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit

Newsfile Corp • 05/11/21

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.

Newsfile Corp • 05/10/21

CYDY Investor Reminder: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Against CytoDyn Inc.

Newsfile Corp • 05/07/21

CytoDyn's Leronlimab Featured on OneNews in Philippines on May 9

GlobeNewsWire • 05/07/21

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages CytoDyn Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CYDY

PRNewsWire • 05/06/21

CytoDyn strikes agreement with AEIH in Brazil to run two coronavirus trials using its flagship drug leronlimab

Proactive Investors • 05/05/21

CytoDyn Reaches Agreement with Albert Einstein Israelite Hospital in Brazil to Conduct Two COVID-19 Trials - a Small Trial in Critically Ill and a Large Trial in Severe Populations

GlobeNewsWire • 05/05/21

Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of CytoDyn Inc. of Deadline in Securities Fraud Class Action Lawsuit

Newsfile Corp • 05/04/21

Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc. (CYDY)

PRNewsWire • 05/03/21

CytoDyn to Hold Webcast on May 5 to Provide Update on Multiple Initiatives

GlobeNewsWire • 05/03/21

Data from 10 Patients with Stage Four Cancer Treated with Leronlimab for Nearly One Year Will Serve as Basis for Pre-Breakthrough Therapy Designation Meeting with FDA

GlobeNewsWire • 05/03/21